caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1457354581

Arvind CavaleM.D.

EndocrinologyFeasterville Trevose, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Arvind Cavale's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 8 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Norristown, PA
145447
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
74233
NAZARETH HOSPITAL1640
Howard Lee
Pulmonary Disease · Yardley, PA
1243
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Norristown, PA
71163
ST MARY MEDICAL CENTER57186
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
4499
JEFFERSON HEALTH - NORTHEAST2953
HOLY REDEEMER HEALTH SYSTEM2043
ABINGTON MEMORIAL HOSPITAL1848
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA1325
Howard Lee
Pulmonary Disease · Yardley, PA
1249
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,239
Unique beneficiaries
—
Total services
2,507
Distinct HCPCS
9
Medicare payment
$125K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 282 Endocrinology providers in PA — top quintile (cohort median 794).
PRESCRIBING · PART D · 2024
Total Rx claims
7,926
Beneficiaries
—
Total drug cost
$3.0M
Distinct drugs
72
Brand share
54.6%
Top prescribed drugs
Levothyroxine Sodium968 claims
Repaglinide681 claims
Tirzepatide379 claims
Rosuvastatin Calcium375 claims
Levothyroxine Sodium322 claims
QUALITY · MIPS · 2024
Final MIPS score
23.0
Quality
0.0
Cost
76.8
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-6.24%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$40
Payment records
2
By payment type
Food and Beverage$40